BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30221736)

  • 41. HBcAg-pulsed dendritic cell vaccine induces Th1 polarization and production of hepatitis B virus-specific cytotoxic T lymphocytes.
    Chen W; Shi M; Shi F; Mao Y; Tang Z; Zhang B; Zhang H; Chen L; Chen L; Xin S; Wang FS
    Hepatol Res; 2009 Apr; 39(4):355-65. PubMed ID: 19889049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C; Peng G; Jin X; Tang J; Chen Z
    Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection.
    Böcher WO; Dekel B; Schwerin W; Geissler M; Hoffmann S; Rohwer A; Arditti F; Cooper A; Bernhard H; Berrebi A; Rose-John S; Shaul Y; Galle PR; Löhr HF; Reisner Y
    Eur J Immunol; 2001 Jul; 31(7):2071-9. PubMed ID: 11449360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.
    Carotenuto P; Artsen A; Niesters HG; Osterhaus AD; Pontesilli O
    J Med Virol; 2009 Feb; 81(2):332-9. PubMed ID: 19107973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
    Li L; Tian YJ; Shen H; Zhao XP; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of therapeutic vaccine candidate against HBeAg pEGFP-N1-C (472-507)-ecdCD40L on dendritic cells.
    Zheng J; Xue H; Zhang H; Wang L; Zheng L; Wang X; Lin X; Jin S; Wu J
    Acta Virol; 2018; 62(2):157-163. PubMed ID: 29895156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
    Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J
    J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent.
    Milich DR; Peterson DL; Schödel F; Jones JE; Hughes JL
    J Virol; 1995 May; 69(5):2776-85. PubMed ID: 7535865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uric acid enhances T cell immune responses to hepatitis B surface antigen-pulsed-dendritic cells in mice.
    Ma XJ; Tian DY; Xu D; Yang DF; Zhu HF; Liang ZH; Zhang ZG
    World J Gastroenterol; 2007 Feb; 13(7):1060-6. PubMed ID: 17373740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway.
    You Z; Huang XF; Hester J; Rollins L; Rooney C; Chen SY
    J Immunol; 2000 Oct; 165(8):4581-91. PubMed ID: 11035100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of Valpha14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of Valpha14+ NKT cells promotes the breakage of CTL tolerance.
    Ito H; Ando K; Ishikawa T; Nakayama T; Taniguchi M; Saito K; Imawari M; Moriwaki H; Yokochi T; Kakumu S; Seishima M
    Int Immunol; 2008 Jul; 20(7):869-79. PubMed ID: 18487227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exosomes from Ub‑HBcAg‑overexpressing dendritic cells induce T‑lymphocyte differentiation and enhance cytotoxic T‑lymphocyte activity.
    Yang Y; Liu K; Zhou W; Dai S
    Exp Ther Med; 2023 Apr; 25(4):167. PubMed ID: 36936705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cationic domains in particle-forming and assembly-deficient HBV core antigens capture mammalian RNA that stimulates Th1-biased antibody responses by DNA vaccination.
    Krieger J; Stifter K; Riedl P; Schirmbeck R
    Sci Rep; 2018 Oct; 8(1):14660. PubMed ID: 30279478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection.
    Chuai X; Wang W; Chen H; Deng Y; Wen B; Tan W
    Antiviral Res; 2014 Jan; 101():68-74. PubMed ID: 24239872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunization with adenovirus LIGHT-engineered dendritic cells induces potent T cell responses and therapeutic immunity in HBV transgenic mice.
    Jiang W; Chen R; Kong X; Long F; Shi Y
    Vaccine; 2014 Jul; 32(35):4565-4570. PubMed ID: 24951859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delivery of Tapasin-modified CTL epitope peptide via cytoplasmic transduction peptide induces CTLs by JAK/STAT signaling pathway in vivo.
    Wu S; Chen X; Tang Y; Zhang Y; Li D; Chen J; Wang J; Tang Z; Zang G; Yu Y
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):181-190. PubMed ID: 29340620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune responses of human T lymphocytes to novel hepatitis B virus-derived peptides.
    Yamamiya D; Mizukoshi E; Kaji K; Terashima T; Kitahara M; Yamashita T; Arai K; Fushimi K; Honda M; Kaneko S
    PLoS One; 2018; 13(6):e0198264. PubMed ID: 29856876
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A mouse model with age-dependent immune response and immune-tolerance for HBV infection.
    Yi X; Yuan Y; Li N; Yi L; Wang C; Qi Y; Gong L; Liu G; Kong X
    Vaccine; 2018 Feb; 36(6):794-801. PubMed ID: 29306503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.